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Rhinoscleroma is a chronic, granulomatous infection that 
most frequently affects the respiratory mucosa, especially 
the nasal cavity and eventually extending through the lower 
respiratory tract. The disease is endemic in some countries 
of Central America (El Salvador and Guatemala), Indonesia, 
India, Poland, Hungary, Russia and some African countries 
as well. It is a rare disease in South America. We report a 
51-year-old male resident of a psychiatric institution in São 
Paulo presenting with progressive nasal obstruction, frontal 
headache, yellowish nasal discharge and a mass extruding 
through the right nasal vestibule. The present case report 
describes a Rhino-Sinus scleroma where histopathology 
was vital in the diagnosis. The patient was treated by 
surgical excision of the nasal mass followed by a course 
of ciprofloxacin. He has remained asymptomatic up to the 
last visit six months following treatment and has shown no 
evidence of recurrence.
Keywords: klebsiella rhinoscleromatis, microscopy, 
rhinoscleroma.
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INTRODUCTION
Rhinoscleroma is a chronic granulomatous, slowly 
progressive infection that affects the nose and other res-
piratory tract structures1. It was first described in 1870 by 
the dermatologist Ferdinando Von Hebra2 and posteriorly 
named respiratory scleroma. The Greek name “skleroma,” 
meaning hard tumefaction, was adopted in 1932 at the 
International Clinical Otorhinolaryngology Conference (in 
Madrid), emphasizing involvement of upper and lower 
airways1,3. It occurs frequently in the nasal fossae, even-
tually extending itself to the larynx, the rhinopharynx, the 
mouth and the paranasal sinuses; the lips, trachea and 
bronchi may also be affected to a lesser degree4,5. Extra-
respiratory involvement has rarely been described1.
Scleroma is endemic in some Central American 
countries (El Salvador and Republic of Guatemala), Indo-
nesia, India, Poland, Hungary, Russia and some African 
countries1,6. In South America the frequency is low1,7.
The first observation of scleroma published in Brazil 
was made by Adolpho Lutz in 18908. Few cases have been 
reported in Brazilian medical literature, thus the reason for 
publishing this case, which includes the histopathology 
and treatment.
CLINICAL CASE PRESENTATION
J.P.S is a 51-year-old brown unmarried male patient 
born in Minas Gerais, coming from Sao Paulo (SP state), 
and living in a psychiatric support institution. He was 
brought to the Otorhinolaryngology unit at the Sao Paulo 
Santa Casa de Misericordia Hospital by his sister, and 
presented a reddish mass in his right nare, with frequent 
bleeding episodes, for the past five months. He also had 
a long history of sneezing, nasal pruritus, thickened and 
yellowish rhinorrhea, bilateral nasal obstruction, and daily 
intense frontal headaches.
On further investigation, he had lost some weight 
(three kilograms) during those five months, and was an 
ex-smoker and ex-drinker of alcoholic beverages, having 
given up these habits four years ago. He had worked as 
a polisher, in contact with chemical products during 10 
years, and had been retired due to a psychiatric condition 
(mental deficiency). He was taking biperiden, chlorpro-
mazine and haloperidol, and lived in a psychiatric support 
institution.
The otorhinolaryngological exam revealed an enlar-
ged nose due to a violet-colored mass with small ulcers, 
a hardened consistency, a smooth surface, and irregular 
borders, which extruded from the right nare. The left nasal 
fossa was obstructed by a complete deviation of the nasal 
septum. It was not possible to introduce a nasopharyngos-
cope. On examination with the Glatzel mirror, both nasal 
fossae were not pervious.
The remaining physical exam was within normal 
limits. Psychiatrically the patient was confused and agitated 
due to mental deficiency.
Computed tomography of the paranasal sinuses 
revealed a lesion with soft tissue attenuation material in 
the nasal fossae, the right maxillary sinus, the anterior 
ethmoid cells, in some posterior ethmoid cells, and in 
part of the frontal sinus to the right. There was minor soft 
tissue attenuation material in the left maxillary sinus. The 
sphenoid sinus and the rhinopharynx were unaltered and 
no bone destruction was observed. (Figures 1 and 2)
Treatment included surgery followed by antibiotics. 
Surgical removal of the tumor from the nasal fossae was 
a sinusectomy through the transmaxillary approach with 
a degloving access route. The specimen was referred to 
pathology for examination. At surgery a 3 cm diameter 
hard whitish-gray mass was found inserted in the right 
maxillary sinus and the right nasal fossa, extending itself 
into the ethmoid sinus; it had a smooth surface with irre-
gular contours and contained pus. Bone structures were 
preserved and the cartilage septum was deviated to the 
left by tumoral compression.
Pathology disclosed nasal mucosa containing a di-
ffuse lymphoplasmacytic inflammatory process with large 
vacuolated macrophages typical of Mikulicz cells and many 
plasmocytes transformed into Russel bodies. (Figure 3)
Ciprofloxacin was used (500 mg. 12/12h for 14 days) 
based on literature data.
The patient returned to the Otorhinolaryngology 
unit in good physical condition and no signs of recurrence 
in the nasal mucosa.
Figure 1. Computed tomography of the paranasal sinuses - coronal 
plane. Soft tissue attenuation material occupies the nasal fossae, the 
right maxillary sinus, and some ethmoid cells. The cartilaginous septum 
is deviated to the left. There is no bone destruction.
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Figure 2. Computed tomography of the paranasal sinuses - axial plane. 
Soft tissue attenuation material occupies the right nasal fossa, the right 
maxillary sinus, and part of the left maxillary sinus. The cartilaginous 
septum is deviated to the left. There is no bone destruction.
Figure 3. Microscopy exam of the nasal mucosa showing a lympho-
plasmacytic infiltrate with Mikulicz cells, Russel bodies and congested 
and dilated blood vessels.
DISCUSSION
Scleroma is a specific granulomatous infection that 
affects the nose and, less frequently, other structures of 
the respiratory tract. It usually affects people with lower 
social and economic status, and is associated with lack of 
hygiene and prolonged contact with infected patients3,9.
The disease progresses in three stages: (1) the ca-
tarrhal stage: patients have non-specific rhinitis symptoms 
that progress to fetid rhinorrhea, crusting and nasal obs-
truction. This stage can last for weeks or months. (2) the 
hypertrophic stage: this stage includes granulation tissue 
with deformity by widening of the nasal pyramid, and 
nasal septum cartilage destruction. Epistaxis, anosmia, and 
anesthesia of the soft palate, among other symptoms, may 
occur. (3) the sclerotic stage: this stage is characterized 
by extensive scarring and laryngeal, and nasal vestibular 
stenosis in severe cases10,11.
Scleroma is an opportunistic disease in immunosup-
pressed patients and has many differential diagnoses, such 
as specific granulomatous diseases caused by bacteria (tu-
berculosis, actinomycosis, syphilis and leprosy), by fungi 
(histoplasmosis, blastomicosis, paracoccidioidomycosis), 
by other parasites (mucocutaneous leishmaniasis), systemic 
diseases (sarcoidosis and Wegener’s granulomatosis), and 
neoplasms (verrucous carcinoma)12.
The patient in our case had a tumor that extruded 
from the right nare. It was typically a hypertrophic stage 
lesion. The first diagnosis, however, was of a neoplasm, al-
though granulomatous diseases had not been excluded.
Given the emotional situation of the patient and 
based on the physical exam and radiographic data, we 
decided for surgery even without a preoperative biopsy. 
The complete specimen was sent to pathology. Frequently 
in these cases biopsies do not provide a final diagnosis, due 
to secondary contamination and insufficient material.
Histopathology defines the diagnosis based on fin-
ding Mikulicz cells and degenerated plasmocytes in Russel 
bodies, described in 1877 by Johann Von Mikulicz13. The 
etiological agent is Klebsiella rhinoscleromatis, a Gram-
negative facultative intracellular encapsulated bacillus, a 
member of the Enterobacteriaceae family identified by 
Von Frisch in 188214.
Mikulicz cells are clear cytoplasm vacuolated his-
tiocytes containing the bacillus. Factors involved in trans-
forming histiocytes into Mikulicz cells are unknown9.
Antibiotic treatment is used as a single treatment to 
eradicate the infection mostly in the catarrhal stage, or as 
ancillary treatment in other stages of the disease to reduce 
mortality and avoid complications. Drug treatment may be 
combined with surgery in cases with granulomatous lesions 
or scarring stenosis. Many antibiotics have been used to 
treat rhinoscleroma. Streptomycin has severe side effects, 
especially on the vestibular system; also resistance to this 
drug has developed in a number of countries. Tetracycline 
requires a prolonged course of treatment and also has sig-
nificant adverse effects. Rifampicin provides good results 
in the treatment of rhinoscleroma, but requires effective 
monitoring of toxicity. Trimethoprim-sulphamethoxazo-
le may be effective and is widely used in Third World 
countries. Recent studies have shown that the quinolones, 
ciprofloxacin and fluoroquinolone readily penetrate the 
tissues and are clinically effective3.
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FINAL COMMENTS
Scleroma is a better name for this clinical entity, 
as it affects both the nasal cavity and the remaining res-
piratory tract. It is a rare condition in our country and 
frequently is difficult to diagnose. This is due to the dise-
ase stages, where patients may present with non-specific 
rhinitis symptoms, signs of granulomatous proliferation 
or scarring.
When the disease progresses with proliferation, it 
may simulate a tumor, as in our patient. At a later stage, 
scarring may produce retraction in any part of the respi-
ratory tract.
Material should be adequate for histopathology. 
A cell infiltrate containing lymphocytes and plasmocytes 
including Mikulicz cells and Russel bodies is highly sugges-
tive of scleroma. The differential diagnosis should be made 
with granulomatous diseases, leprosy and tuberculosis, all 
of which may be identified with specific histopathological 
techniques.
Isolating Klebsilela Rhinoescleromatis using special 
culture media is not always possible in these cases.
The correct diagnosis is given based on histopatho-
logical findings and the clinical history, which includes 
information on living conditions and the work environ-
ment.
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